Immunic Therapeutics logo

Senior Medical Science Liaison (MSL)

Immunic Therapeutics

Any City, USRemotePosted 1 day ago$190,000 - $225,000/year
Full TimeMid LevelMedical AffairsBiotechnology
Original posting ↗

Summary

We are seeking a Senior Medical Science Liaison (MSL) to serve as a field-based scientific expert and the primary scientific interface between the medical community and Immunic Medical Affairs, with a primary focus on multiple sclerosis within neurology and neuroimmunology.

Job description

Summary

We are seeking a Senior Medical Science Liaison (MSL) to serve as a field-based scientific expert and the primary scientific interface between the medical community and Immunic Medical Affairs, with a primary focus on multiple sclerosis within neurology and neuroimmunology.

You will work as an individual contributor within a defined geographic territory, engaging healthcare professionals in fair and balanced scientific exchange on disease biology, clinical research, and emerging therapeutic data. You will partner closely with Medical Directors, Scientific Communications, and Evidence Generation teams.

You will join a growing Medical Affairs organization grounded in scientific rigor, intellectual curiosity, and meaningful collaboration, where the insights you gather in the field will help shape scientific communication, medical strategy, and ongoing development activities.

Responsibilities

  • Engage neurologists and other healthcare professionals in scientific dialogue on multiple sclerosis, neuroimmunology, and emerging therapeutic approaches.
  • Respond to questions from healthcare professionals with fair, balanced, and scientifically rigorous medical information, including clinical data, safety, adherence, and emerging evidence, in a compliant manner.
  • Develop and execute a territory engagement plan aligned with Immunic's Medical Affairs and therapeutic area objectives.
  • Identify and engage clinicians, investigators, and institutions relevant to multiple sclerosis and neuroimmunology within your territory.
  • Gather insights from clinicians on clinical practice patterns, unmet medical needs, and emerging scientific questions, and communicate them to Medical Affairs leadership to inform medical and development strategy.
  • Provide targeted, directed support for investigator-initiated studies, collaborative research, and real-world evidence initiatives, including identifying potential clinical trial sites and investigators.
  • Support scientific exchange related to ongoing or completed clinical studies when appropriate.
  • Stay current with emerging science and evolving clinical practice through regular literature review and participation in regional scientific meetings and congresses.
  • Partner with Medical Directors, Scientific Communications, and Evidence Generation teams to ensure consistent scientific communication, and provide scientific education to internal colleagues under guidance from Medical Affairs leadership.
  • Conduct all activities in compliance with applicable regulatory, legal, and company policies governing scientific exchange.

Qualifications & Education

  • Advanced scientific or clinical degree (PhD, PharmD, MD, or NP/PA with research experience) preferred, at least 3 years of field medical experience.
  • Strong communication skills and the ability to engage in scientific dialogue with healthcare professionals.
  • Ability to travel 50% of the time, primarily within the assigned territory.
  • Experience in neurology, neuroimmunology, or multiple sclerosis necessary.
  • Prior experience as an MSL or in clinical or research roles interacting with healthcare professionals preferred.
  • Familiarity with the multiple sclerosis clinical landscape and emerging therapies preferred.

Requirements

  • Advanced scientific or clinical degree (PhD, PharmD, MD, or NP/PA with research experience) preferred
  • At least 3 years of field medical experience
  • Strong communication skills and ability to engage in scientific dialogue with healthcare professionals
  • Ability to travel 50% of the time, primarily within the assigned territory
  • Experience in neurology, neuroimmunology, or multiple sclerosis necessary
  • Prior experience as an MSL or in clinical or research roles interacting with healthcare professionals preferred
  • Familiarity with the multiple sclerosis clinical landscape and emerging therapies preferred

Benefits

  • Equity
  • Bonus

Company overview

Immunic Therapeutics (Nasdaq: IMUX) is a late-stage biotechnology company pioneering the development of novel oral therapies for chronic inflammatory and autoimmune diseases, with a primary focus on neurologic conditions such as multiple sclerosis (MS). Headquartered in New York City with additional operations in Gräfelfing, Germany, the company is dedicated to advancing a clinical pipeline of orally administered, small molecule therapeutics. Its lead program, vidofludimus calcium (IMU-838), is a first-in-class oral therapy that combines neuroprotective effects through nuclear receptor-related 1 (Nurr1) activation with anti-inflammatory and anti-viral properties via selective dihydroorotate dehydrogenase (DHODH) inhibition. Vidofludimus calcium is currently in Phase 3 clinical trials (ENSURE program) for relapsing multiple sclerosis, with top-line data expected by the end of 2026, and has demonstrated promising therapeutic activity in Phase 2 trials for both relapsing-remitting and progressive MS. The company's pipeline also includes earlier-stage programs, such as IMU-856 targeting gastrointestinal diseases and IMU-381 for gastrointestinal applications. Founded in 2016, Immunic employs approximately 51-200 people and is transitioning toward becoming a fully integrated commercial-stage biotechnology company.

Explore more jobs of your matchFind more biopharma roles with GetBioJob.